E.J. Shpall

1.8k total citations
48 papers, 1.4k citations indexed

About

E.J. Shpall is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, E.J. Shpall has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 21 papers in Hematology and 10 papers in Genetics. Recurrent topics in E.J. Shpall's work include Hematopoietic Stem Cell Transplantation (20 papers), Cancer Treatment and Pharmacology (7 papers) and Mesenchymal stem cell research (6 papers). E.J. Shpall is often cited by papers focused on Hematopoietic Stem Cell Transplantation (20 papers), Cancer Treatment and Pharmacology (7 papers) and Mesenchymal stem cell research (6 papers). E.J. Shpall collaborates with scholars based in United States, Canada and France. E.J. Shpall's co-authors include R B Jones, W. P. Peters, Jon P. Gockerman, Gregg A. Olsen, Robert C. Bast, RB Jones, Marcos de Lima, S Matthes, Simon N. Robinson and P. J. Cagnoni and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

E.J. Shpall

48 papers receiving 1.4k citations

Peers

Countries citing papers authored by E.J. Shpall

Since Specialization

Citations

This map shows the geographic impact of E.J. Shpall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.J. Shpall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.J. Shpall more than expected).

Fields of papers citing papers by E.J. Shpall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.J. Shpall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.J. Shpall. The network helps show where E.J. Shpall may publish in the future.

Co-authorship network of co-authors of E.J. Shpall

This figure shows the co-authorship network connecting the top 25 collaborators of E.J. Shpall. A scholar is included among the top collaborators of E.J. Shpall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.J. Shpall. E.J. Shpall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Umbilical cord blood graft engineering: challenges and opportunities 2015 ·Bone Marrow Transplantation ·Philip A. Thompson, Katy Rezvani, Chitra Hosing, Betül Oran, Amanda Olson, Uday Popat, Amin M. Alousi, Nina Shah, Simrit Parmar, Catherine M. Bollard, Patrick J. Hanley, Partow Kebriaei, Laurence J.N. Cooper, Joshua Kellner, I K McNiece, E.J. Shpall	16
2	Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL 2012 ·Bone Marrow Transplantation ·Partow Kebriaei, Timothy Madden, X. Wang, Peter F. Thall, Celina Ledesma, Marcos de Lima, E.J. Shpall, Chitra Hosing, M. Qazilbash, Uday Popat, Amin M. Alousi, Yago Nieto, Richard Champlin, R B Jones, Börje S. Andersson	10
3	Ex vivo expansion of umbilical cord blood for transplantation 2010 ·Best Practice & Research Clinical Haematology ·Samuel Tung, (unknown), Simon N. Robinson, Marcos de Lima, E.J. Shpall	44
4	Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies 2009 ·Haematologica ·Carlos A. Ramos, Rima M. Saliba, (unknown), Ola Khorshid, E.J. Shpall, Sergio Giralt, Poliana Patah, Chitra Hosing, Uday Popat, (unknown), Issa F. Khouri, Yago Nieto, Richard E. Champlin, Marcos de Lima	34
5	AML-loaded DC generate Th1-type cellular immune responses in vitro 2006 ·Cytotherapy ·Dajun Xing, William K. Decker, (unknown), Simon N. Robinson, Hong Yang, H L Segal, Seán O’Connor, Xin Yao, Krishna V. Komanduri, J. McMannis, Roy B. Jones, Marcos de Lima, Richard E. Champlin, E.J. Shpall	7
6	A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts 2006 ·Bone Marrow Transplantation ·Hong Yang, Connie J. Eaves, M. Lima, (unknown), R. Champlin, J. McMannis, Simon N. Robinson, Ting Niu, William K. Decker, Dajun Xing, Jia Q. Ng, (unknown), Xin Yao, Allen Eaves, (unknown), Börje S. Andersson, E.J. Shpall	6
7	Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies 2006 ·Bone Marrow Transplantation ·Lazaros J. Lekakis, Sergio Giralt, Daniel Couriel, E.J. Shpall, Chitra Hosing, Issa F. Khouri, P Anderlini, M Körbling, Thomas G. Martin, R. Champlin, Marcos de Lima	27
8	Nonmyeloablative allogeneic hematopoietic stem cell transplantation for congenital sideroblastic anemia 2003 ·Bone Marrow Transplantation ·Bruno C. Medeiros, J F Kolhouse, Pablo J. Cagnoni, John Ryder, Yago Nieto, Rachel Rabinovitch, E.J. Shpall, SI Bearman, Roy B. Jones, Peter A. McSweeney	8
9	Intensive chemotherapy for progressive chronic lymphocytic leukemia administered early after a nonmyeloablative allograft 2001 ·Bone Marrow Transplantation ·Yago Nieto, SI Bearman, E.J. Shpall, (unknown), (unknown), (unknown), (unknown)	6
10	FAHCT accreditation: common deficiencies during on-site inspections 2000 ·Cytotherapy ·Phyllis I. Warkentin, (unknown), E.J. Shpall	11
11	High-dose therapy with autologous hematopoietic cell support as salvage treatment for patients with breast cancer who have relapsed after previous high-dose chemotherapy 1999 ·Bone Marrow Transplantation ·SI Bearman, (unknown), P. J. Cagnoni, E.J. Shpall, Yago Nieto, Maureen Ross, WP Peters, R B Jones	4
12	Post-mortem incidental finding of cytomegalovirus oophoritis after an allogeneic stem cell transplant 1999 ·Bone Marrow Transplantation ·Yago Nieto, Maureen Ross, Roberto Gianani, E.J. Shpall, P. J. Cagnoni, SI Bearman, (unknown)	7
13	Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics 1999 ·Bone Marrow Transplantation ·P. J. Cagnoni, S Matthes, (unknown), (unknown), E.J. Shpall, (unknown)	69
14	Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer 1999 ·PubMed ·Ian McNiece, Roy B. Jones, Pablo J. Cagnoni, Scott I. Bearman, Yago Nieto, E.J. Shpall	32
15	Optic disc and retinal microvasculopathy after high-dose chemotherapy and autologous hematopoietic progenitor cell support 1999 ·Bone Marrow Transplantation ·(unknown), (unknown), (unknown), Salomon M. Stemmer, (unknown), (unknown), E.J. Shpall, (unknown), (unknown), R B Jones	20
16	Microchimerism and Tolerance following Intrauterine Transplantation and Transfusion for α-Thalassemia-1 1998 ·Fetal Diagnosis and Therapy ·Anthony Hayward, Daniel R. Ambruso, Frederick C. Battaglia, Timothy A. Donlon, (unknown), Roger Giller, J. C. Hobbins, Y. Edward Hsia, Ralph Quinones, E.J. Shpall, Elizabeth Trachtenberg, Patricia J. Giardina	52
17	Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) Response to FDA (Docket No. 97N-0068) 1997 ·Journal of Hematotherapy ·E.J. Shpall	1
18	High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4–9 involved axillary lymph nodes 1997 ·Bone Marrow Transplantation ·(unknown), (unknown), BJ Bolwell, (unknown), E.J. Shpall, P. J. Cagnoni, (unknown), (unknown), (unknown), M. H. Purdy, Maureen Ross, (unknown)	48
19	Acute Lung Injury Following Treatment With High-Dose Cyclophosphamide, Cisplatin, and Carmustine: Pharmacodynamic Evaluation of Carmustine 1993 ·JNCI Journal of the National Cancer Institute ·R.B. Jones, S Matthes, E.J. Shpall, Jennifer Fisher, Salomon M. Stemmer, Christopher Dufton, Janet K. Stephens, Scott I. Bearman	67
20	High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. 1988 ·Journal of Clinical Oncology ·W. P. Peters, E.J. Shpall, R B Jones, Gregg A. Olsen, Robert C. Bast, Jon P. Gockerman, (unknown)	317

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact